References
- 1. Adams L.A., Lindor K.D.: Nonalcoholic fatty liver disease. Ann Epidemiol 2007, 17, 863–869.
- 2. Aviram M., Rosenblat M.: Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 2004, 37, 1304–1316.
- 3. Baird G.D.: Primary ketosis in the high-producing dairy cow: clinical and subclinical disorders, treatment, prevention, and outlook. J Dairy Sci 1982, 65, 1–10.
- 4. Bouwstra R.J., Goselink R.M.A., Dobbelaar P., Nielen M., Newbold J.R., Werven V.T.: The relationship between oxidative damage and vitamin E concentration in blood, milk, and liver tissue from vitamin E supplemented and nonsupplemented periparturient heifers. J Dairy Sci 2008, 91, 977–987.
- 5. Farid A.S., Honkawa K., Fath E.M., Nonaka N., Horii Y.: Serum paraoxonase-1 as biomarker for improved diagnosis of fatty liver in dairy cows. BMC Vet Res 2013, 9, 73.
- 6. Gerloff B.J., Herdt T., Emery R.S.: Relationship of hepatic lipidosis to health and performance in dairy cattle. J Am Vet Med Assoc 1986, 188, 845–850.
- 7. Gan K.N., Smolen A., Eckerson H.W., Du B.N.L.: Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991, 19, 100–106.
- 8. Kulka M., Bełtowski J., Kluciński W., Orłowska M., Kołodziejska J., Kleczkowski M: Serum paraoxonase-1 activity of dairy Holstein-Fresian cows in different lactation stages-preliminary study. Pol J Vet Sci 2014, 17, 143–147.
- 9. LeBlanc S.: Monitoring metabolic health of dairy cattle in the transition period. J Reprod Dev 2010, 56, 29–35.
- 10. Oetzel G.R. Monitoring and testing dairy herds for metabolic disease. Vet Clin North Am Food Anim Pract 2004, 20, 651–674.
- 11. Padilla L., Shibano K.I., Inoue J., Tohru T., Tohru H.: Plasma vitamin C concentration is not related to the incidence of ketosis in dairy cows during the early lactation period. Vet Med Sci 2015, 67, 883–886.
- 12. Pessayre D., Mansouri A., Haouzi D., Fromenty B.: Hepatotoxicity due to mitochondrial dysfunction. Cell Biol Toxicol 1999, 15, 367–373.
- 13. Seifi H.A., Gorji-Dooz M., Mohri M., Dalir-Naghadeh B., Farzaneh N.: Variations of energy-related biochemical metabolites during transition period in dairy cows. Comp Clin Path 2007, 16, 253–258.
- 14. Turk R., Juretić D., Gereš D., Svetina A., Turk N., Flegar-Meštrić Z.: Influence of oxidative stress and metabolic adaptation on PON-1 activity and MDA level in transition dairy cows. Anim Reprod Sci 2008, 108, 98–106.
- 15. Videla L.A.: Energy metabolism, thyroid calorigenesis, and oxidative stress: functional and cytotoxic consequences. Redox Rep 2000, 5, 265–275.
- 16. White H.M.: The Role of TCA cycle anaplerosis in ketosis and fatty liver in periparturient dairy cows. Animals 2015, 5, 793–802.
- 17. Xu C., Xu Q., Chen Y.Y., Wei Y., Cheng X., Hong Y.Z., Kui L.Z., Tai Y.S., Zi Y.Z.: FGF-21: promising biomarker for detecting ketosis in dairy cows. Vet Res Commun 2016, 40, 47–57.
- 18. Xu C., Wang Z.: Comparative proteomic analysis of livers from ketotic cows. Vet Res Commun 2008, 32, 263–273.